Canton Strategic Holdings, Inc. (CNTN)vsBeiGene, Ltd. (ONC)
CNTN
Canton Strategic Holdings, Inc.
$2.30
+9.52%
HEALTHCARE · Cap: $167.33M
ONC
BeiGene, Ltd.
$350.84
-0.74%
HEALTHCARE · Cap: $39.69B
Smart Verdict
WallStSmart Research — data-driven comparison
BeiGene, Ltd. generates 409617% more annual revenue ($6.13B vs $1.50M). ONC leads profitability with a 10.7% profit margin vs 0.0%. ONC earns a higher WallStSmart Score of 64/100 (C+).
CNTN
Avoid26
out of 100
Grade: F
ONC
Buy64
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for CNTN.
Margin of Safety
+80.0%
Fair Value
$1758.06
Current Price
$350.84
$1407.22 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Earnings expanding 166.7% YoY
Conservative balance sheet, low leverage
Growing faster than its price suggests
Revenue surging 29.6% year-over-year
Areas to Watch
0.0% revenue growth
0.0% earnings growth
Distress zone — elevated risk
Smaller company, higher risk/reward
Premium valuation, high expectations priced in
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : CNTN
The strongest argument for CNTN centers on Price/Book.
Bull Case : ONC
The strongest argument for ONC centers on EPS Growth, Debt/Equity, PEG Ratio. Revenue growth of 29.6% demonstrates continued momentum. PEG of 0.75 suggests the stock is reasonably priced for its growth.
Bear Case : CNTN
The primary concerns for CNTN are Revenue Growth, EPS Growth, Altman Z-Score.
Bear Case : ONC
The primary concerns for ONC are P/E Ratio, Altman Z-Score. A P/E of 62.9x leaves little room for execution misses.
Key Dynamics to Monitor
CNTN profiles as a value stock while ONC is a growth play — different risk/reward profiles.
CNTN carries more volatility with a beta of 1.50 — expect wider price swings.
ONC is growing revenue faster at 29.6% — sustainability is the question.
ONC generates stronger free cash flow (596M), providing more financial flexibility.
Bottom Line
ONC scores higher overall (64/100 vs 26/100) and 29.6% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Canton Strategic Holdings, Inc.
HEALTHCARE · BIOTECHNOLOGY · USA
Canton Strategic Holdings, Inc. (CNTN) operates as a diversified investment firm focused on maximizing shareholder value through strategic acquisitions and the management of a diverse asset portfolio across multiple sectors. With an emphasis on value-driven investments and operational efficiencies, CNTN is strategically positioned to leverage emerging market opportunities and propel sustainable growth. The company’s robust approach to strategic planning and investment execution aims to deliver superior returns while effectively navigating the complexities of the financial landscape, making it an attractive option for institutional investors seeking stability and growth potential.
BeiGene, Ltd.
HEALTHCARE · BIOTECHNOLOGY · USA
BeiGene, Ltd., an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company is headquartered in Camana Bay, the Cayman Islands.
Visit Website →Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?